Medpace Holdings (MEDP) Cash & Current Investments (2015 - 2026)

Medpace Holdings (MEDP) has reported Cash & Current Investments for 12 consecutive years, with $502.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments rose 985.02% year-over-year to $502.7 million; the trailing twelve-month figure through Jun 2026 stood at $502.7 million (up 985.02% YoY), and the FY2025 full-year result was $497.0 million, down 25.75% from the prior year.
• Cash & Current Investments fell to $502.7 million in Q2 2026 per MEDP's latest filing, from $652.7 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $669.4 million in Q4 2024 and bottomed at $28.3 million in Q4 2022.
• Historically, Cash & Current Investments has averaged $293.4 million across 5 years, with a median of $265.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments tumbled 93.87% in 2022, then surged 1205.37% in 2024.
• Over 5 years, Cash & Current Investments stood at $28.3 million in 2022, then soared by 768.38% to $245.4 million in 2023, then soared by 172.74% to $669.4 million in 2024, then fell by 25.75% to $497.0 million in 2025, then grew by 1.13% to $502.7 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $502.7 million, $652.7 million, and $497.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.